By Cecilia Butini

Fresenius SE & Co KGaA said Tuesday that its infusion and transfusion subsidiary Fresenius Kabi AG is expanding its Austrian facilities with an investment of 60 million euros ($72.31 million).

The investment, which will run through 2023, will focus on expanding capacity as well as an upgrade of infrastructure at Fresenius Kabi's production plant in Graz and at a packing center in Werndorf, the company said.

It added that the number of jobs the expansion will create, in addition to the existing 900 in Graz, cannot yet be determined.

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

February 09, 2021 05:43 ET (10:43 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Fresenius SE & Co KGaA Charts.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Fresenius SE & Co KGaA Charts.